128 related articles for article (PubMed ID: 30394649)
1. Generation of a pregnancy cohort for medicine utilisation and medicine safety studies in New Zealand.
Donald S; Barson D; Horsburgh S; Sharples K; Parkin L
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1335-1343. PubMed ID: 30394649
[TBL] [Abstract][Full Text] [Related]
2. Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005-2015.
Donald S; Sharples K; Barson D; Horsburgh S; Parkin L
Eur J Clin Pharmacol; 2020 Jun; 76(6):887-896. PubMed ID: 32248249
[TBL] [Abstract][Full Text] [Related]
3. Challenges of using primary care electronic medical records in the UK to study medications in pregnancy.
Cea-Soriano L; García Rodríguez LA; Fernández Cantero O; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):977-85. PubMed ID: 23813653
[TBL] [Abstract][Full Text] [Related]
4. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.
Blotière PO; Weill A; Dalichampt M; Billionnet C; Mezzarobba M; Raguideau F; Dray-Spira R; Zureik M; Coste J; Alla F
Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):763-770. PubMed ID: 29763992
[TBL] [Abstract][Full Text] [Related]
5. Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005-2015.
Donald S; Sharples K; Barson D; Horsburgh S; Parkin L
PLoS One; 2020; 15(6):e0234153. PubMed ID: 32484824
[TBL] [Abstract][Full Text] [Related]
6. Healthcare databases in Europe for studying medicine use and safety during pregnancy.
Charlton RA; Neville AJ; Jordan S; Pierini A; Damase-Michel C; Klungsøyr K; Andersen AM; Hansen AV; Gini R; Bos JH; Puccini A; Hurault-Delarue C; Brooks CJ; de Jong-van den Berg LT; de Vries CS
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):586-94. PubMed ID: 24664855
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data.
Richards N; Reith D; Stitely M; Smith A
BMC Pregnancy Childbirth; 2018 Apr; 18(1):84. PubMed ID: 29625554
[TBL] [Abstract][Full Text] [Related]
8. Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996-2006.
Artama M; Gissler M; Malm H; Ritvanen A;
Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):729-38. PubMed ID: 21626607
[TBL] [Abstract][Full Text] [Related]
9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
10. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
Mikolajczyk RT; Kraut AA; Garbe E
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
[TBL] [Abstract][Full Text] [Related]
12. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
[TBL] [Abstract][Full Text] [Related]
13. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry.
Shahir AK; Briggs N; Katsoulis J; Levidiotis V
Nephrology (Carlton); 2013 Apr; 18(4):276-84. PubMed ID: 23441694
[TBL] [Abstract][Full Text] [Related]
14. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.
Cleary BJ; Butt H; Strawbridge JD; Gallagher PJ; Fahey T; Murphy DJ
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):408-17. PubMed ID: 20099251
[TBL] [Abstract][Full Text] [Related]
15. Utilization of drugs with pregnancy exposure registries during pregnancy.
Illoh OA; Toh S; Andrade SE; Hampp C; Sahin L; Gelperin K; Taylor L; Bird ST
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):604-611. PubMed ID: 29516585
[TBL] [Abstract][Full Text] [Related]
16. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.
Taylor LG; Thelus Jean R; Gordon G; Fram D; Coster T
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):510-7. PubMed ID: 25833769
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and patterns of antidepressant drug use during pregnancy.
Ververs T; Kaasenbrood H; Visser G; Schobben F; de Jong-van den Berg L; Egberts T
Eur J Clin Pharmacol; 2006 Oct; 62(10):863-70. PubMed ID: 16896784
[TBL] [Abstract][Full Text] [Related]
18. Quantification of missing prescriptions in commercial claims databases: results of a cohort study.
Cepeda MS; Fife D; Denarié M; Bradford D; Roy S; Yuan Y
Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):386-392. PubMed ID: 28120552
[TBL] [Abstract][Full Text] [Related]
19. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
[TBL] [Abstract][Full Text] [Related]
20. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015.
Engeland A; Bjørge T; Klungsøyr K; Hjellvik V; Skurtveit S; Furu K
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):995-1004. PubMed ID: 29920833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
